Multi-Component Breath Alcohol Intervention Phase 3
Recruiting now · Not applicable
Conditions studied: Alcohol Use, Alcohol Drinking, Drinking Behavior
In brief
This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.
Key facts
- Study ID
- NCT06994962
- Run by
- Northeastern University
- People needed
- 90
- Starts
- 2025-05-01
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2026-05-20
Who can join
Age: 18 and older, up to 25. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- No subject may:
- Have been in inpatient or intensive outpatient treatment within the past 12 months
- Have used a smartphone application to facilitate moderate drinking more than 1 time within the past 12 months
- Meet DSM-5 criteria for current substance use disorder with the exception of tobacco use disorder, mild or moderate alcohol use disorder or mild cannabis use disorder.
- History of alcohol withdrawal or medically-assisted detoxification as individuals with this history will likely be in need of more intensive treatment than is offered in this study.
- Be psychotic or otherwise severely psychiatrically disabled
- Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders).
Where it is running
- Northeastern University — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.